Melanoma antigen preferentially/PRAME, Human (His)

MedChem Express

Melanoma antigen preferentially/PRAME, Human (His)

10

Research Use Only

90.00

PRAME

PRAME nuclear receptor transcriptional regulator

CT130, MAPE, OIP-4, OIP4, melanoma antigen preferentially expressed in tumors, Opa-interacting protein OIP4, cancer/testis antigen 130, opa-interacting protein 4, preferentially expressed antigen in melanoma, preferentially expressed antigen of melanoma

Melanoma antigen preferentially expressed in tumors

PRAME is located in the CRL2 E3 ubiquitin-protein ligase complex and directs ubiquitination and degradation, specifically targeting the truncated MSRB1/SEPX1 selenoprotein.It is recruited to active promoter regions and is involved in chromatin regulation.Melanoma antigen preferentially/PRAME, Human (His) is the recombinant human-derived Melanoma antigen preferentially/PRAME, expressed by E.coli , with N-6*His labeled tag.

-20°C

41116100

Human